David K. Clawson
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Protein Kinase Regulation and GTPase Signaling, Blood Coagulation and Thrombosis Mechanisms, Asymmetric Synthesis and Catalysis, Estrogen and related hormone effects
Most-Cited Works
- → Crystal structure of the obese protein Ieptin-E100(1997)676 cited
- → Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease(1997)619 cited
- → Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2(1995)214 cited
- → Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution(1991)201 cited
- → Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor(2017)170 cited
- → Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor(2013)110 cited
- →